india formulations business

Telangana's booming food sector, encompassing processing, agri-tech, and exports, has spurred demand for skilled professionals. The state's higher education council has launched a new BBA in Food Technology, Food Security, and Agriculture, integrating science, business, and policy. This interdisciplinary program aims to equip graduates for evolving industry needs, bridging the gap between academic knowledge and practical market demands.

Xi dealt with Trump as his equal, pitting Beijing’s grand strategic concerns against Washington’s transactionalism. Yes, both sides outwardly agreed on some issues. But Beijing is playing a long game

Nighttime skincare is gaining prominence as people recognise its crucial role in skin repair and regeneration, aligning with the body's natural circadian rhythm. Experts emphasise that prioritising gentle cleansing, targeted nourishment with actives like retinol and essential hydration supports the skin's overnight recovery. This shift reflects a move towards simpler, consistent self-care routines focused on long-term skin health and well-being.

Stock market recommendations: Granules, and UltraTech Cement have been picked as the top stock recommendations from the week starting May 4, 2026 by Motilal Oswal Wealth Management Research Desk. Let’s take a look:

Senior Vice President Dino Bekis explains the architecture behind a partnership that doubles as the opening move in Qualcomm's broader India ambition

The Reserve Bank of India has unveiled significant regulatory reforms to boost business ease and financial market depth. Key changes include streamlining board agendas, simplifying MSME onboarding onto digital platforms, and strengthening capital adequacy by removing certain provisioning norms. These measures aim to enhance lending capacity and liquidity amid global uncertainties.

India's push for 'Jan Vishwas' faces a stark contradiction as authorities increasingly use stringent NDPS and BNS laws against licensed pharmaceutical stockists. Despite clear regulations under the Drugs and Cosmetics Act, businesses dealing in common cough syrups are being prosecuted, blurring lines between regulation and criminality. This trend risks eroding trust and undermining the rule of law.

Stock market recommendations: Ipca Laboratories, and AU Small Finance Bank are the stocks that Motilal Oswal Wealth Management Research Desk recommends buying for the week starting March 30, 2026. Target prices and potential upsides are listed below:

Indian pharmaceutical giants like Sun Pharma, Torrent, and Dr. Reddy's have launched affordable semaglutide, a groundbreaking weight-loss drug, following Novo Nordisk's patent expiry. This move significantly reduces therapy costs, offering patients greater access to treatment for obesity and type-2 diabetes. Torrent Pharma even introduced both oral and injectable versions, marking a significant step in addressing India's growing metabolic disorder crisis.

Stock market recommendations: Ipca Laboratories, and Hindalco are the top stocks that Motilal Oswal Wealth Management Research Desk has picked for this week starting March 23, 2026.

Uttarakhand Chief Minister Pushkar Singh Dhami met Prime Minister Narendra Modi in Delhi, highlighting the state's development progress and seeking support for key infrastructure and connectivity projects. Dhami extended an invitation to the Prime Minister to visit Uttarakhand and presented him with local specialties. The meeting also covered initiatives in tourism, spiritual economy, and entrepreneurship.

The Bombay High Court has upheld the Reserve Bank of India's 2022 amalgamation scheme for Punjab and Maharashtra Cooperative (PMC) Bank with Unity Small Finance Bank. The court ruled the move was in public interest, ensuring depositors receive their full principal and interest, a stark contrast to liquidation outcomes. This decision protects depositors and strengthens the banking system.

Nomura cut Petronet LNG's target price due to West Asia crisis impacting volumes, while HSBC maintained a hold on Blue Star, citing demanding valuations. BofA Securities remains constructive on HDFC Bank despite chairman's exit, and Citigroup upgraded Dr Lal Pathlabs, expecting strong revenue growth and attractive valuations.

India's vehicle scrappage policy aims for a circular economy but faces implementation hurdles. Gaps in infrastructure, particularly Automated Testing Stations and Registered Vehicle Scrapping Facilities, and regional disparities hinder progress. Overcoming these challenges through policy alignment, technology, and informal sector integration is crucial for success.

Consumer commissions, once envisioned for swift justice, now face systemic delays and structural deficits, mirroring civil courts. Vacancies and procedural ambiguity hinder accessibility, leading to prolonged litigation and eroding public trust. Urgent reforms are needed to restore efficiency and consumer-centricity.

Maharashtra Chief Minister Devendra Fadnavis proposed a dedicated policy and plug-and-play manufacturing hubs to position the state as a global chemicals hub. He assured industry leaders of government support through policy interventions and infrastructure development, emphasizing collaboration with ICC and academic institutions for skill enhancement and sector growth.

The actor's visits to Kedarnath have drawn attention after the temple panel said non-Hindus must submit an affidavit declaring faith, bringing into focus new entry conditions at key Hindu shrines ahead of the Char Dham Yatra

Alembic Pharmaceuticals experienced a 12.1% dip in Q4 net profit, reaching Rs 156.63 crore, despite a 16.7% surge in revenue to Rs 1,769.64 crore. While India formulations and US revenue showed growth, the company's full-year revenue increased by 7% to Rs 6,672 crore. Despite the profit decline, the company remains optimistic about sustained growth across various segments.

The numbers are staggering: on February 27 the combined market capitalisation of BSE-listed companies was Rs 46,325,200.41 crore. As of March 13, 2025, it has fallen to Rs 42,939,960.29 crore. That’s a loss of almost Rs 33 lakh crore in investor wealth over a span of two weeks and nine trading sessions!

Biocon Biologics (BBL) is selling its dermatology and nephrology branded formulations business to Eris Lifesciences for Rs 366 crore. The deal includes the company's small molecule brands and will result in over 120 employees transitioning to Eris. The divestment is in line with BBL's strategy to focus on core therapy areas. Eris Lifesciences believes the acquisition will deliver value to shareholders.

AHMEDABAD: The Vadodara-based pharmaceuticals player has reorganised its business operations for sharper focus on formulations and contract research.